Search by Drug Name or NDC
NDC 00338-0683-04 Potassium Chloride in Dextrose 5; 150 g/100mL; mg/100mL Details
Potassium Chloride in Dextrose 5; 150 g/100mL; mg/100mL
Potassium Chloride in Dextrose is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE.
Product Information
| NDC | 00338-0683 |
|---|---|
| Product ID | 0338-0683_f1a588f6-403d-40da-a135-a082007dfd3a |
| Associated GPIs | 79993002102020 |
| GCN Sequence Number | 001949 |
| GCN Sequence Number Description | potassium chloride in D5W IV SOLN 20 MEQ/L INTRAVEN |
| HIC3 | C1D |
| HIC3 Description | POTASSIUM REPLACEMENT |
| GCN | 62111 |
| HICL Sequence Number | 014775 |
| HICL Sequence Number Description | POTASSIUM CHLORIDE IN 5 % DEXTROSE IN WATER |
| Brand/Generic | Generic |
| Proprietary Name | Potassium Chloride in Dextrose |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Potassium Chloride and Dextrose Monohydrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 5; 150 |
| Active Ingredient Units | g/100mL; mg/100mL |
| Substance Name | DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA017634 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00338-0683-04 (00338068304)
| NDC Package Code | 0338-0683-04 |
|---|---|
| Billing NDC | 00338068304 |
| Package | 1000 mL in 1 BAG (0338-0683-04) |
| Marketing Start Date | 1979-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |